EU OKs first-line use of AZ’ Faslodex

27th July 2017 Uncategorised 0

EU regulators are permitting the use of AstraZeneca’s breast cancer drug Faslodex at an earlier stage of the treatment pathway in patients with certain forms of the disease.

More: EU OKs first-line use of AZ’ Faslodex
Source: News